AMJ Global Technology - Quarter Report: 2023 February (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended February 28, 2023
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ____________ to ____________
Commission File Number: 333-194055
KANGE CORP. |
(Exact name of registrant as specified in its charter) |
Nevada |
| 33-1230169 |
(State or other jurisdiction of incorporation) |
| (IRS Employer Identification Number) |
11724 Ventura Blvd Suite B, Studio City, CA 91604
(Address of principal executive offices)
(818) 853-7033
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated Filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
As of April 18, 2023, the Company had 90,523,323 shares of common stock outstanding.
KANGE CORP.
INDEX
|
| Page | ||
|
|
| ||
|
|
|
| |
| 3 |
| ||
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
| 4 |
| |
| 7 |
| ||
| 7 |
| ||
|
|
|
|
|
|
|
| ||
|
|
|
|
|
| 8 |
| ||
| 8 |
| ||
| 8 |
| ||
| 8 |
| ||
| 8 |
| ||
| 8 |
| ||
| 9 |
| ||
|
|
|
|
|
| 10 |
2 |
Table of Contents |
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
Kange Corp.
Table of Contents
3 |
Table of Contents |
Kange Corp
Condensed Balance Sheets
(Unaudited)
|
| February 28, |
|
| November 30, |
| ||
|
| 2023 |
|
| 2022 |
| ||
ASSETS |
|
|
|
|
|
| ||
Current Assets |
|
|
|
|
|
| ||
Cash |
| $ | - |
|
| $ | - |
|
Total Current Assets |
|
| - |
|
|
| - |
|
|
|
|
|
|
|
|
|
|
TOTAL ASSETS |
| $ | - |
|
| $ | - |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' DEFICIT |
|
|
|
|
|
|
|
|
Current Liabilities |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
| $ | 1,010 |
|
| $ | 5,655 |
|
Due to related parties |
|
| 33,398 |
|
|
| 11,098 |
|
Total Current Liabilities |
|
| 34,408 |
|
|
| 16,753 |
|
|
|
|
|
|
|
|
|
|
Stockholders' Deficit |
|
|
|
|
|
|
|
|
Common stock, $0.001 par value, 750,000,000 shares authorized, 89,623,323 shares issued and outstanding |
|
| 89,623 |
|
|
| 89,623 |
|
Additional paid-in capital |
|
| 3,255,107 |
|
|
| 3,255,107 |
|
Accumulated deficit |
|
| (3,379,138 | ) |
|
| (3,361,483 | ) |
Total Stockholders' Deficit |
|
| (34,408 | ) |
|
| (16,753 | ) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
| $ | - |
|
| $ | - |
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
F-1 |
Table of Contents |
Kange Corp
Condensed Statements of Operations
(Unaudited)
|
| Three Months Ended |
| |||||
|
| February 28, |
| |||||
|
| 2023 |
|
| 2022 |
| ||
|
|
|
|
|
|
| ||
Revenues |
| $ | - |
|
| $ | - |
|
Operating Expenses |
|
|
|
|
|
|
|
|
General and administrative |
|
| 1,800 |
|
|
| 155 |
|
Professional fees |
|
| 15,855 |
|
|
| - |
|
Management compensation |
|
| - |
|
|
| 273,074 |
|
Total operating expenses |
|
| 17,655 |
|
|
| 273,229 |
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
| (17,655 | ) |
|
| (273,229 | ) |
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
Loss on settlement of debt - related party |
|
| - |
|
|
| (1,714,069 | ) |
Total other expenses |
|
| - |
|
|
| (1,714,069 | ) |
|
|
|
|
|
|
|
|
|
Net loss |
| $ | (17,655 | ) |
| $ | (1,987,298 | ) |
|
|
|
|
|
|
|
|
|
Basic and diluted loss per common share |
| $ | (0.00 | ) |
| $ | (0.05 | ) |
Basic and diluted weighted average common shares outstanding |
|
| 89,623,323 |
|
|
| 41,676,444 |
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
F-2 |
Table of Contents |
Kange Corp
Condensed Statement of Changes in Stockholders’ Deficit
(Unaudited)
For the Three Months Ended February 28, 2023
|
|
|
|
|
|
|
| Additional |
|
|
|
|
| Total |
| |||||
|
| Common Stock |
|
| Paid in |
|
| Accumulated |
|
| Stockholders' |
| ||||||||
|
| Shares |
|
| Amount |
|
| Capital |
|
| Deficit |
|
| Deficit |
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Balance - November 30, 2022 |
|
| 89,623,323 |
|
| $ | 89,623 |
|
| $ | 3,255,107 |
|
| $ | (3,361,483 | ) |
| $ | (16,753 | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss for the period |
|
| - |
|
|
| - |
|
|
| - |
|
|
| (17,655 | ) |
|
| (17,655 | ) |
Balance - February 28, 2023 |
|
| 89,623,323 |
|
| $ | 89,623 |
|
| $ | 3,255,107 |
|
| $ | (3,379,138 | ) |
| $ | (34,408 | ) |
For the Three Months Ended February 28, 2022
|
|
|
|
|
| Additional |
|
|
|
| Total |
| ||||||||
|
| Common Stock |
|
| Paid in |
|
| Accumulated |
|
| Stockholders’ |
| ||||||||
|
| Shares |
|
| Amount |
|
| Capital |
|
| Deficit |
|
| Deficit |
| |||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Balance - November 30, 2021 |
|
| 14,396,323 |
|
| $ | 14,396 |
|
| $ | 1,276,084 |
|
| $ | (1,361,587 | ) |
| $ | (71,107 | ) |
Common stock issued for settlement of debt - related party |
|
| 65,227,000 |
|
|
| 65,227 |
|
|
| 1,715,949 |
|
|
| - |
|
|
| 1,781,176 |
|
Common stock issued for compensation - related party |
|
| 10,000,000 |
|
|
| 10,000 |
|
|
| 263,074 |
|
|
| - |
|
|
| 273,074 |
|
Net loss |
|
| - |
|
|
| - |
|
|
| - |
|
|
| (1,987,298 | ) |
|
| (1,987,298 | ) |
Balance - February 28, 2022 |
|
| 89,623,323 |
|
| $ | 89,623 |
|
| $ | 3,255,107 |
|
| $ | (3,348,885 | ) |
| $ | (4,155 | ) |
The accompanying notes are an integral part of these condensed unaudited financial statements.
F-3 |
Table of Contents |
Kange Corp
Condensed Statements of Cash Flows
(Unaudited)
|
| Three Months Ended |
| |||||
|
| February 28, |
| |||||
|
| 2023 |
|
| 2022 |
| ||
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
| ||
Net loss |
| $ | (17,655 | ) |
| $ | (1,987,298 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Stock based compensation - related party |
|
| - |
|
|
| 273,074 |
|
Loss on settlement of debt - related party |
|
| - |
|
|
| 1,714,069 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
| (4,645 | ) |
|
| 155 |
|
Net cash used in operating activities |
|
| (22,300 | ) |
|
| - |
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Proceeds from related party |
|
| 22,300 |
|
|
| - |
|
Net cash provided by financing activities |
|
| 22,300 |
|
|
| - |
|
|
|
|
|
|
|
|
|
|
Net change in cash for the period |
|
| - |
|
|
| - |
|
Cash at beginning of period |
|
| - |
|
|
| - |
|
Cash at end of period |
| $ | - |
|
| $ | - |
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL CASH FLOW INFORMATION: |
|
|
|
|
|
|
|
|
Cash paid for income taxes |
| $ | - |
|
| $ | - |
|
Cash paid for interest |
| $ | - |
|
| $ | - |
|
|
|
|
|
|
|
|
|
|
NON-CASH INVESTING AND FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Common stock issued for settlement of debt - related party |
| $ | - |
|
| $ | 67,107 |
|
The accompanying notes are an integral part of these unaudited condensed financial statements.
F-4 |
Table of Contents |
KANGE CORP.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
FEBRUARY 28, 2023
NOTE 1 – BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES
Business
Kange Corp. (“Kange,” the “Company,” “we,” “us,” or “our”) was incorporated under the laws of the State of Nevada on August 16, 2013. We are a start-up company developing mobile software products for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry.
Basis of Presentation
The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the financial statements are condensed and do not include all of the information and footnotes required by GAAP for complete financial statements.
In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the results of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year. The accompanying unaudited interim financial statements should be read in conjunction with the financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended November 30, 2022, as filed with the SEC on February 3, 2023.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.
NOTE 2 – GOING CONCERN AND LIQUIDITY CONSIDERATION
Going Concern
The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company used cash in operating activities of $22,300 for the three months ended February 28, 2023. The Company had an accumulated deficit of $3,379,138 at February 28, 2023. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital and loans from related parties to sustain its current level of operations. The Company is in the process of securing working capital from investors for common stock, convertible notes payable, and/or strategic partnerships. No assurance can be given that the Company will be successful in these efforts.
F-5 |
Table of Contents |
The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
NOTE 3 – RELATED PARTY TRANSACTIONS
In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such a time that the Company can support its operations or attains adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by shareholders. Amounts represent advances or amounts paid in satisfaction of liabilities. The advances are non-interest bearing, considered temporary in nature, and have not been formalized by a promissory note.
During the three months ended February 28, 2022, the Company’s board of directors approved the issuance of 65,227,000 shares of common stock for settlement of $67,107 due to AMJ Global Entertainment, LLC, a related party controlled by the Company’s CEO and director. The shares were valued at $1,781,176, resulting in a loss of settlement on debt of $1,714,069.
During the three months ended February 28, 2022, the Company’s board of directors approved the issuance of 10,000,000 shares of common stock as a one-time bonus to the Company’s CEO for services rendered as CEO and director. The Company recognized compensation of $273,074 for the issuance of 10,000,000 shares of common stock.
During the three months ended February 28, 2023, and 2022, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $22,300 and $0 by paying for operating expenses on behalf of the Company.
At February 28, 2023 and November 30, 2022, the Company owed $33,398 and $11,098 to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director. The amounts are unsecured, non-interest bearing and due on demand.
NOTE 4 – COMMON STOCK
Common Stock
The Company has authorized common shares of 750,000,000, par value $0.001 per share. Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive rights.
On January 27, 2022 the Company adopted the Board Resolution and issued 65,227,000 shares of common stock against the amount owed to AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director, and 10,000,000 shares of common stock as stock-based compensation to the Company’s CEO and director (see Note 3).
There were 89,623,323 shares of common stock issued and outstanding as of February 28, 2023 and November 30, 2022.
NOTE 5 – SUBSEQUENT EVENTS
The Company has evaluated events occurring subsequent to the balance sheet date through the date these unaudited condensed financial statements were issued and determined there are no additional events requiring disclosure, except as follows:
On March 5, 2023, the Company’s board of directors approved to appoint advisory board members and has determined four advisors. The Company’s board of directors approved to issue 250,000 shares of common stock to each three advisors and 150,000 shares of common stock to another advisor as compensation for serving as the advisory board.
According to advisory board member agreement, the advisor shall be entitled to an additional 150,000 shares of common stock on one year anniversary. The advisory agreement shall expire upon written notice by the Company to the advisor.
On March 9, 2023, pursuant to advisory agreements the Company issued a total of 900,000 shares of common stock to four advisors.
F-6 |
Table of Contents |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Rule 175 of the Securities Act of 1933, as amended, and Rule 3b-6 of the Securities Act of 1934, as amended, that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our industry, our beliefs and our assumptions. Words such as “anticipate,” “expects,” “intends,” “plans,” “believes,” “seeks” and “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this Form 10-Q. Investors should carefully consider all of such risks before making an investment decision with respect to the Company’s stock. The following discussion and analysis should be read in conjunction with our financial statements and summary of selected financial data for Kange Corp. Such a discussion represents only the best present assessment from our Management.
Description of Company
The Company is a start-up company that was incorporated in Nevada on August 16, 2013. We are a start-up company developing mobile software products for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc. During 2017, we began focusing on the intersection of technology and wholistic technology-based health treatments. We retained an advisor having substantial experience in the technology sector, and two former professional athletes to advise us regarding sports health issues and treatments. We intend to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry.
We have had limited operations and have been issued a “going concern” opinion by our auditor on our November 30, 2022, audited financial statements based upon our reliance on related party advances and the sale of our common stock as the sole source of funds for our operations for the near future.
The following Management Discussion and Analysis should be read in conjunction with the financial statements and accompanying notes included in this Form 10-Q.
Reports to Security Holders
We intend to furnish our shareholders annual reports containing financial statements audited by our independent registered public accounting firm and to make available quarterly reports containing unaudited financial statements for each of the first three quarters of each year. We file Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K with the Securities and Exchange Commission in order to meet our timely and continuous disclosure requirements. We may also file additional documents with the Commission if they become necessary in the course of our company’s operations.
The public may read and copy any materials that we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is www.sec.gov.
4 |
Table of Contents |
Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the condensed financial statements and notes thereto for the three months ended February 28, 2023, and 2022, and related management discussion herein.
Our financial statements are stated in U.S. Dollars and are prepared in accordance with generally accepted accounting principles of the United States (“GAAP”).
Going Concern
The Company’s financial statements are prepared in accordance with GAAP applicable to a going concern. This contemplates the realization of assets and the liquidation of liabilities in the normal course of business. Currently, the Company does not have material assets, nor does it have operations or a source of revenue sufficient to cover its operation costs and allow it to continue as a going concern. The Company has an accumulated deficit of $3,379,138. The Company will be dependent upon the raising of additional capital through placement of common stock in order to implement its business plan, or merge with an operating company. There can be no assurance that the Company will be successful in either situation in order to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts of and classification of liabilities that might be necessary in the event the company cannot continue in existence. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern.
The officers and directors are committed to advancing certain operating costs of the Company, including compliance costs for being a public company.
For the Three Months Ended February 28, 2023 and 2022:
Our operating results for the three months ended February 28, 2023 and 2022, and the changes between those periods for the respective items are summarized as follows:
|
| Three Months Ended |
|
|
|
| ||||||
|
| February 28, |
|
| Change |
| ||||||
|
| 2023 |
|
| 2022 |
|
| Amount |
| |||
Operating loss |
| $ | 17,655 |
|
| $ | 273,229 |
|
| $ | (255,574 | ) |
Other expense |
|
| - |
|
|
| 1,714,069 |
|
|
| (1,714,069 | ) |
Net loss |
| $ | 17,655 |
|
| $ | 1,987,298 |
| $ | (1,969,643 | ) |
We did not earn any operating revenues for the three months ended February 28, 2023 and 2022.
The Company incurred a net loss of $17,655 during the three months ended February 28, 2023, compared to a net loss of $1,987,298 for the three months ended February 28, 2022. The decrease in net loss was primarily due to a decrease in the operating expenses of $255,574 and the other expenses of $1,714,069 due to a loss on settlement of related party debt during the three months ended February 28th, 2022.
During the three months ended February 28, 2023 and 2022, our operating expenses were primarily attributed to professional expenses of $15,855 and $0, general and administrative expenses of $1,800 and $155 and management compensation of $0 and $273,074, respectively.
During the three months ended February 28, 2023 and 2022, the other expenses were attributed to loss on the settlement of debt to a company controlled by our CEO of $0 and $1,714,069, respectively.
Liquidity and Capital Resources
Based upon our current financial condition, we do not have sufficient cash to operate our business at the current level for the next twelve months. We intend to fund operations through debt and/or equity financing arrangements, which may be insufficient to fund expenditures or other cash requirements. We plan to seek additional financing in a private equity offering to secure funding for operations. There can be no assurance that we will be successful in raising additional funding. If we are not able to secure additional funding, the implementation of our business plan will be impaired. There can be no assurance that such additional financing will be available to us on acceptable terms or at all.
5 |
Table of Contents |
Working Capital
The following table presents our working capital position as of February 28, 2023, and November 30, 2022:
|
| As of |
|
| As of |
|
|
|
| |||
|
| February 28, |
|
| November 30, |
|
| Change |
| |||
|
| 2023 |
|
| 2022 |
|
| Amount |
| |||
Current assets |
| $ | - |
|
| $ | - |
|
| $ | - |
|
Current liabilities |
| $ | 34,408 |
|
| $ | 16,753 |
|
| $ | 17,655 |
|
Working capital (deficiency) |
| $ | (34,408 | ) |
| $ | (16,753 | ) |
| $ | (17,655 | ) |
The change in working capital during the three months ended February 28, 2023, was primarily due to an increase in current liabilities of $17,655.
As of February 28, 2023, current liabilities were comprised of $1,010 in accounts payable and accrued liabilities and $33,398 in due to a related party, compared to $5,655 in accounts payable and accrued liabilities and $11,098 in due to related party as of November 30, 2022.
Cash Flow
We fund our operations with cash received from advances from officers and related parties and issuances of equity.
The following table presents our cash flow for the three months ended February 28, 2023 and 2022:
|
| Three Months Ended |
| |||||
|
| February 28, |
| |||||
|
| 2023 |
|
| 2022 |
| ||
Cash used in operating activities |
| $ | (22,300 | ) |
| $ | - |
|
Cash used in investing activities |
|
| - |
|
|
| - |
|
Cash provided by financing activities |
|
| 22,300 |
|
|
| - |
|
Net change in cash for the period |
| $ | - |
|
| $ | - |
|
Cash Flows from Operating Activities
We did not generate positive cash flows from operating activities for the three months ended February 28, 2023 and 2022.
For the three months ended February 28, 2023, net cash flows used in operating activities was $22,300, consisting of a net loss of $17,655 increased by a decrease in accounts payable of $4,645.
For the three months ended February 28, 2022, net cash flows used in operating activities was $0, consisting of a net loss of $1,987,298 reduced by stock-based compensation–related party of $273,074, a loss on settlement of debt–related party of $1,714,069, and a change in accounts payable and accrued liabilities of $155.
Cash Flows from Investing Activities
For the three months ended February 28, 2023 and 2022, no cashflows were used in investing activities.
6 |
Table of Contents |
Cash Flows from Financing Activities
During the three months ended February 28, 2023 and 2022, AMJ Global Entertainment LLC, a related party controlled by the Company’s CEO and director advanced to the Company an amount of $22,300 and $0 by paying for operating expenses on behalf of the Company.
Off-Balance Sheet Arrangements
The Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.
Critical Accounting Policies
Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
As the Company is a “smaller reporting company,” this item is inapplicable.
ITEM 4. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
The Securities and Exchange Commission defines the term “disclosure controls and procedures” to mean the company’s controls and other procedures of an issuer that are designed to ensure that information required to be disclosed in the reports that it files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains such a simple system of controls and procedures in an effort to ensure that all information which it is required to disclose in the reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified under the SEC’s rules and forms and that information required to be disclosed is accumulated and communicated to principal executive and principal financial officers to allow timely decisions regarding disclosure.
As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified. Our chief executive officer and chief financial officer also concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this report to provide reasonable assurance of the achievement of these objectives.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or 15d-15 of the Exchange Act that occurred during the quarter ended February 28, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
7 |
Table of Contents |
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The Company is not a party to any significant pending legal proceedings other than as disclosed below, and no other such proceedings are known to be contemplated. No director, officer or affiliate of the Company, and no owner of record or beneficial owner of more than 5.0% of the securities of the Company, or any associate of any such director, officer or security holder is a party adverse to the Company or has a material interest adverse to the Company in reference to pending litigation.
ITEM 1A. RISK FACTORS.
Not applicable.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
None.
ITEM 5. OTHER INFORMATION.
None.
8 |
Table of Contents |
ITEM 6. EXHIBITS.
Exhibit |
| Description |
|
|
|
| ||
| ||
| ||
| ||
| ||
101* |
| Inline XBRL Document Set for the condensed financial statements and accompanying notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q. |
104* |
| Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. |
____________
* Filed herewith.
9 |
Table of Contents |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| KANGE CORP. |
| |
|
|
|
|
Date: April 19, 2023 | By: | /s/ Dr. Arthur Malone, Jr. |
|
|
| Dr. Arthur Malone, Jr. |
|
|
| Chief Executive Officer, Chief Financial Officer and Director |
|
10 |